Peginesatide

( DrugBank: Peginesatide / KEGG DRUG: Peginesatide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
283	後天性赤芽球癆	3

283. 後天性赤芽球癆

臨床試験数 : 19 / 薬物数 : 36 - (DrugBank : 23) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 102

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00314795 (ClinicalTrials.gov)	April 6, 2006	13/4/2006	Efficacy and Safety of Peginesatide(AF37702) in the Treatment of Anemia in Participants With Chronic ...	An Open-Label Study to Investigate the Efficacy and Safety of AF37702 Injection in the Treatment of ...	Anemia;Chronic Kidney Disease;Chronic Renal Failure;Pure Red Cell Aplasia	Drug: Peginesatide	Takeda	NULL	Completed	18 Years	N/A	All	22	Phase 2	France;Germany;United Kingdom
2	EUCTR2005-004944-30-DE (EUCTR)	08/03/2006	20/12/2005	A Phase 2 study of AF37702 Injection for anemia in patients with pure red cell aplasia.	An Open-Label Study to Investigate the Efficacy and Safety of AF37702 Injection (Hematide™) in the T ...	Anemia caused by Antibody-Mediated Pure Red Cell Aplasia in Patients with Chronic Kidney Disease Med ...	Product Name: AF37702 Injection Product Code: AF37702, Hematide INN or Proposed INN: peginesatide Other ...	Takeda Development Centre Europe Ltd	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 2	Germany;United Kingdom
3	EUCTR2005-004944-30-GB (EUCTR)	23/02/2006	09/12/2005	A Phase 2 study of AF37702 Injection for anemia in patients with pure red cell aplasia.	An Open-Label Study to Investigate the Efficacy and Safety of AF37702 Injection in the Treatment of ...	Anemia caused by Antibody-Mediated Pure Red Cell Aplasia in Patients with Chronic Kidney Disease Med ...	Product Name: AF37702 Injection Product Code: AF37702, Hematide INN or Proposed INN: peginesatide Other ...	Takeda Development Centre Europe Ltd	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 2	Germany;United Kingdom

First Previous1Next Last